COCH and Hodgkins lymphoma: While the observed molecular defects upon overexpression of mutant cochlin can be an indicator of variant pathogenicity, in vitro overexpression studies lack sensitivity to predict how individual pathogenic variants in cochlin affect phenotypic outcomes of HL.